|4Feb 28, 10:27 AM ET

Agwunobi, M.D. Andrew C. 4

4 · HUMANA INC · Filed Feb 28, 2023

Insider Transaction Report

Form 4
Period: 2023-02-24
Agwunobi, M.D. Andrew C.
Seg. President, Home Solutions
Transactions
  • Award

    Options

    2023-02-24+2,8382,838 total
    Exercise: $510.24Exp: 2030-02-24Humana Common (2,838 underlying)
  • Award

    Restricted Stock Units

    2023-02-24+735735 total
    Humana Common (735 underlying)
Holdings
  • Humana Common

    182
  • Options

    Exercise: $430.62Exp: 2029-03-01Humana Common (3,086 underlying)
    3,086
  • Restricted Stock Units

    Humana Common (523 underlying)
    523
Footnotes (5)
  • [F1]Right to buy pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 3/1/2022, vesting in three annual increments from 3/1/23 to 3/1/25.
  • [F2]Right to buy pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 2/24/2023, vesting in three annual increments from 2/24/24 to 2/24/26.
  • [F3]Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).
  • [F4]Restricted stock units granted to reporting person on 3/1/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24.
  • [F5]Restricted stock units granted to reporting person on 2/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES